ADIPOQ and obstructive sleep apnea syndrome: These findings suggest that miR-107 and adiponectin could serve as promising biomarkers for diagnosing OSA, and targeting miR-107 to modulate metabolic factors may offer novel therapeutic approaches for improving OSA management.